5-HTP Properties – Serotonin Precursor for Sleep and Mood 2026

According to data from the National Health Fund, in 2023, over 8.5 million packages of antidepressants from the SSRI group were purchased in Poland, representing a 26% increase compared to 2019 (NFZ, 2024). The growing demand for mood and sleep quality support has led to increasing interest in supplements that act on the serotoninergic system. Among them, 5-HTP, or 5-hydroxytryptophan, holds a special place.

5-HTP is a direct precursor of serotonin (5-HT), obtained from the seeds of the African plant Griffonia simplicifolia. Unlike L-tryptophan, it bypasses competitive transport across the blood-brain barrier and undergoes a one-step decarboxylation to serotonin. It sounds simple, but as reviews from Alternative Medicine Review and Cochrane databases show, the clinical evaluation of this molecule is complex, and safety requires attention.

In this paper, we examine the pharmacology of 5-HTP, scientific evidence from Birdsall's studies (1998) and Cochrane (Shaw 2002), practical dosages, as well as critical warnings regarding combinations with SSRIs, SNRIs, and the history of EMS contamination from 1989. The text is informational and does not replace consultation with a physician, especially a psychiatrist or clinical pharmacist.

KEY INFORMATION
– 5-HTP is a direct precursor of serotonin (5-HT), derived from seeds Griffonia simplicifolia, bypassing the competitive transport of tryptophan across the blood-brain barrier (Birdsall, Altern Med Rev, 1998).
– The typical clinical dose in depression studies is 150-300 mg daily, divided into 2-3 doses. Sleep support usually involves 50-100 mg in the evening (NIH ODS, 2024).
– DO NOT combine 5-HTP with SSRIs, SNRIs, TCAs, or MAO inhibitors. The risk of serotonin syndrome (fever, tremors, confusion) is potentially life-threatening.
– Do not use during pregnancy, while breastfeeding, or in children without medical supervision. There is a lack of safety data.
– Choose products with a certificate of analysis (CoA), keeping in mind the historical EMS episode from 1989 related to the contamination of serotonin precursors.

What is 5-HTP and how does it work in the body?

5-HTP (5-hydroxytryptophan) is a naturally occurring amino acid that serves as an intermediary in the serotonin biosynthesis pathway in the human body. In the enzymatic pathway, L-tryptophan is hydroxylated to 5-HTP and then decarboxylated to 5-HT. As a dietary supplement, it bypasses the first, rate-limiting step, providing a ready substrate for AADC decarboxylase (Birdsall, Altern Med Rev, 1998).

In practice, this means that 5-HTP crosses the blood-brain barrier via active transport of aromatic amino acids. In serotoninergic neurons, it is converted into serotonin by aromatic L-amino acid decarboxylase (AADC), an enzyme that requires vitamin B6 (PLP) as a cofactor. Vitamin B6 and magnesium are often added to 5-HTP supporting preparations.

The molecule differs chemically from L-tryptophan by the presence of an additional hydroxyl group at position 5 of the indole ring. This slight modification alters the affinity for enzymes and transporters. Unlike tryptophan, 5-HTP does not compete with other amino acids for LAT1 transport, which translates into higher efficiency in raising 5-HT levels in the brain.

Where does commercial 5-HTP come from?

Commercial 5-HTP is almost entirely extracted from the seeds Griffonia simplicifolia, of a shrub native to West Africa (Ghana, Ivory Coast). The seeds contain 6-14% 5-HTP by weight, making them the richest known botanical source (NIH ODS, 2024). Chemical synthesis is possible but not commercially viable.

The extraction process involves crushing the seeds, solvent extraction or water-alcohol extraction, and then crystallization. The quality of the final raw material depends on chemical purity and the content of impurities, including the infamous "Peak X," whose presence has historically been linked to EMS cases (Klarskov, J Rheumatol, 2003). Reputable suppliers publish CoA certificates for each batch.

Seeds Griffonia simplicifolia contain 6-14% 5-HTP by weight, making them the richest known botanical source and explaining why commercial preparations are almost exclusively sourced from plant extraction rather than chemical synthesis (NIH ODS, 2024). Standardization usually ranges from 95-99% purity, which should be verified in the certificate of analysis.

How does 5-HTP affect serotonin and melatonin?

After oral administration, 5-HTP reaches peak blood concentration (Cmax) in 1-2 hours, and the half-life is approximately 4-7 hours (NIH ODS, 2024). Part of the dose is decarboxylated in the intestine and liver to peripheral serotonin, while some crosses the blood-brain barrier. Only centrally synthesized serotonin affects mood, sleep, and pain perception.

Serotonin (5-HT) is a neurotransmitter widely distributed in the brain, acting through at least 14 receptor subtypes (5-HT1A to 5-HT7). It regulates mood, anxiety, sleep, appetite, intestinal peristalsis, pain perception, and body temperature. A deficiency of serotonin has been linked to depression, obsessive-compulsive disorders, and some types of insomnia (NIMH, 2024).

Role in melatonin production

In the pineal gland, serotonin undergoes a two-step conversion to melatonin: first to N-acetylserotonin by the enzyme AANAT, then to melatonin by HIOMT. This process is active at night, regulated by darkness and the suprachiasmatic nucleus (SCN). Higher levels of the 5-HT precursor in the evening may support melatonin synthesis in individuals with deficiency.

Therefore, some clinicians recommend 5-HTP in the evening, 30-60 minutes before sleep, in doses of 50-100 mg, as support for falling asleep. However, it is important to remember that 5-HTP is not melatonin. It acts indirectly and requires a proper circadian rhythm and a functioning pineal gland. In older individuals or those with pineal gland dysfunction, melatonin itself may be more effective.

5-HT2A receptor and mood

Among serotoninergic receptors, 5-HT1A and 5-HT2A are particularly important for mood. Activation of 5-HT1A reduces anxiety and has antidepressant effects. Activation of 5-HT2A is associated with neuroplasticity but also with psychedelic effects at very high concentrations (beyond the therapeutic range of 5-HTP). Increasing the available pool of serotonin with 5-HTP affects the entire spectrum of receptors (PubMed, 2020).

What do the studies say – Birdsall 1998 and Cochrane Shaw 2002?

The most frequently cited review of 5-HTP is Birdsall's work from 1998, published in Alternative Medicine Review. The author analyzed 27 clinical studies on depression and concluded that 5-HTP at doses of 150-300 mg/d showed comparable efficacy to tricyclic antidepressants, with a better tolerance profile (Birdsall, Altern Med Rev, 1998). However, this is an assessment from the perspective of 1998.

A more critical stance was taken by the Cochrane Review authored by Shaw et al. in 2002. The authors searched MEDLINE, EMBASE, and PsycINFO databases and found 108 studies on 5-HTP and tryptophan in depression. Of these, only 2 met the rigorous methodological quality criteria (randomization, blind trial, placebo, appropriate patient group). Conclusion: the data is promising but insufficient for clinical recommendations.

What accounts for this discrepancy? Birdsall presents mechanistic arguments and a sum of observational evidence. Cochrane applies a higher bar, which only a small portion of studies meet. Currently, 5-HTP is cautiously evaluated as a possible support, not as a first-line therapy (NIH ODS, 2024).

Sleep – preliminary data

In smaller studies from the 1970s and 1980s, 5-HTP at doses of 200-600 mg in the evening prolonged REM sleep time and shortened sleep latency (Wyatt et al., 1971; Soulairac, 1977). Later methodological works were sparse. A review Journal of Psychopharmacology from 2010 summarized that 5-HTP may be helpful in sleep disorders related to anxiety, but there is a lack of large RCTs (J Psychopharmacol, 2010).

Migraines and fibromyalgia

Another substantial body of literature on 5-HTP consists of studies on migraines and fibromyalgia. In several small RCTs from the 1980s, doses of 400-600 mg/d reduced the frequency of migraine attacks comparably to propranolol or methysergide. Individual studies on fibromyalgia suggested pain reduction and improved sleep after 100 mg three times daily. However, the evidence is limited, and a review Cephalalgia from 2018 recommends caution in interpretation (Cephalalgia, 2018).

Cochrane Review (Shaw et al., 2002) identified 108 studies on 5-HTP and tryptophan in depression, of which only 2 met the methodological quality criteria, leading to the conclusion that while the data suggest efficacy, the evidence base is too weak for clinical recommendations as a first-line therapy (Cochrane Database, 2002).

Interpretative nuance: popular market compilations refer to Birdsall, ignoring the more rigorous Cochrane review. Meanwhile, these two sources are not in contradiction. Birdsall shows a signal of efficacy, Cochrane shows that this signal has not been confirmed by modern-class studies. An informed consumer should be aware of both.

Practical dose of 5-HTP – from 50 to 300 mg daily

In clinical reviews, the dose of 5-HTP in depression typically ranges from 150-300 mg daily, divided into 2-3 doses (NIH ODS, 2024). For sleep support, 50-100 mg is used 30-60 minutes before bedtime. In studies on migraines and fibromyalgia, doses of 300-600 mg/day appear, but these are specialized areas. The principle of "start low, go slow" also applies to 5-HTP.

Practical starting protocol: 50 mg after lunch for 5-7 days. If tolerance is good, add 50 mg in the evening. After another 5-7 days, consider a third dose of 50 mg after breakfast, reaching a total of 150 mg/d. Higher doses (200-300 mg/d) require consultation with a physician or pharmacist.

Form and timing of administration

5-HTP is available in capsules of 50 mg, 100 mg, and 200 mg, sometimes in extended-release (ER) form. The standard form acts faster, while ER reduces gastrointestinal issues and provides more stable concentrations. Taking it with a meal limits nausea but may also slightly reduce absorption. Some preparations contain added vitamin B6 (AADC cofactor) and magnesium.

The timing of administration depends on the goal: for mood, usually 2-3 doses during the day; for sleep, a single evening dose 30-60 minutes before going to bed. Combining with carbohydrates may aid tryptophan transport and enhance the serotoninergic signal, although for 5-HTP, this effect is less than for L-tryptophan.

When to expect an effect?

The effect on sleep can be noticeable as early as the first evening at doses of 100-200 mg. The impact on mood requires 2-4 weeks of regular use, similar to SSRIs (Birdsall, 1998). Lack of effect after 4-6 weeks at doses up to 300 mg/day should be a signal to consult a psychiatrist and consider other therapy methods. 5-HTP is not a "magic cure for depression."

From the perspective of the Bucha editorial office: In conversations with clients, we observe that those most satisfied with 5-HTP are those who use it short-term (4-8 weeks) as support during periods of increased stress, rather than as a long-term therapy. Prolonged use beyond 12 weeks without medical consultation is not advisable due to the lack of safety data on chronic supplementation.

Warning – serotonin syndrome with SSRIs, SNRIs, and other medications

The most serious risk associated with 5-HTP is serotonin syndrome, a potentially life-threatening condition resulting from excessive activation of serotoninergic receptors. According to NIH ODS (2024), the risk is significantly increased when combining 5-HTP with medications that enhance 5-HT transmission, including SSRIs, SNRIs, TCAs, and MAO inhibitors. This is an absolute contraindication without psychiatric supervision.

Serotonin syndrome manifests as a triad: altered consciousness (confusion, agitation), autonomic hyperactivity (fever, tachycardia, sweating, diarrhea), and neuromuscular symptoms (tremors, myoclonus, hyperreflexia, rigidity). In more severe forms, fever above 41 degrees Celsius, seizures, and multi-organ failure may occur. This condition requires immediate hospitalization.

List of drugs requiring special caution

Among the most important groups of medications that should not be combined with 5-HTP without explicit medical approval are: SSRIs (sertraline, escitalopram, paroxetine, fluoxetine, citalopram); SNRIs (venlafaxine, duloxetine); TCAs (amitriptyline, clomipramine, imipramine); MAO inhibitors (moclobemide, selegiline, phenelzine). Also, tramadol, dextromethorphan, some migraine triptans, and lithium increase the risk (NIH ODS, 2024).

Recreational substances like MDMA and LSD also affect the serotoninergic system, and their combination with 5-HTP is dangerous. Some supplements (St. John's wort, S-adenosylmethionine, high-dose L-tryptophan) may cumulatively raise serotoninergic signaling. The safety principle: one source of influence on 5-HT, no more.

What to do if I am already taking SSRIs?

Do not discontinue medication without consulting a psychiatrist. Sudden discontinuation of SSRIs leads to withdrawal syndrome. Adding 5-HTP to ongoing SSRI therapy without medical supervision is an even worse option. If you are considering incorporating 5-HTP, discuss it with your treating psychiatrist or clinical pharmacist. Sometimes a safer alternative will be to modify the medication therapy itself.

Combining 5-HTP with SSRIs, SNRIs, TCAs, or MAO inhibitors carries the risk of serotonin syndrome, manifesting as fever above 38 degrees Celsius, tremors, myoclonus, confusion, and in extreme cases, multi-organ failure. NIH ODS (2024) classifies this interaction as one of the most serious warnings regarding the supplement.

Safety, pregnancy, and EMS history

The safety profile of 5-HTP in monotherapy is moderately good. The most common side effects are nausea, diarrhea, abdominal pain, drowsiness, and headaches, occurring in 10-20% of users (NIH ODS, 2024). They usually resolve after 1-2 weeks or after reducing the dose. The extended-release form and taking it with meals limit gastrointestinal issues.

5-HTP is not recommended during pregnancy and breastfeeding due to a lack of safety data. Serotonin crosses the placenta and may affect the development of the fetal nervous system. Also, in children, 5-HTP is not routinely used, although in individual pediatric studies on migraines and nighttime anxiety attacks, doses of 0.3-0.5 mg/kg body weight have been used under medical supervision.

The history of EMS – a lesson from 1989

In 1989, the USA experienced an epidemic outbreak of eosinophilia-myalgia syndrome (EMS), a systemic disease characterized by fever, muscle pain, eosinophilia, and sometimes lung involvement. The outbreak included over 1500 cases, including 37 deaths. An investigation revealed that the source was a contaminated batch of L-tryptophan from a single factory in Japan (Showa Denko). The FDA then withdrew tryptophan from the US market (FDA, 1990).

Subsequent isolated cases of EMS have sporadically been linked to 5-HTP, which was found to contain the impurity labeled "Peak X." Klarskov et al. described cases in J Rheumatol 2003. Contemporary reputable 5-HTP manufacturers test the raw material for the presence of Peak X and publish certificates of analysis. Choosing a product with a CoA and from a known supplier is a form of rational risk management.

Carcinoid tumor – rare but important

In patients with a carcinoid tumor of the intestine, the endogenous level of serotonin is high. Adding 5-HTP may exacerbate symptoms of carcinoid syndrome (flushing, diarrhea, bronchospasm). This is a rare indication for contraindication but mandatory in medical history before starting supplementation.

Collaboration with a psychiatrist and when to seek help?

5-HTP does not replace consultation with a psychiatrist or family doctor. According to the OECD report Health at a Glance (2023) Poland has one of the lower rates of psychiatrists per 100,000 inhabitants in the EU, making access to specialists difficult. Nevertheless, depression, anxiety disorders, and chronic insomnia require medical evaluation. Supplementation can be supportive, not primary therapy.

Alarm signals include: persistent low mood for more than 2 weeks, suicidal thoughts, significant weight loss or appetite, inability to function at work or in family, insomnia lasting over a month. In such situations, the first step should be to contact a psychiatrist or psychologist, not to reach for the supplement shelf. In case of suicidal thoughts – call 112 or the Emotional Crisis Helpline for Adults at 116 123.

What should be discussed with a doctor?

If you decide to take 5-HTP and are under psychiatric care, prepare a list of currently taken medications, including OTC and other supplements. Ask about the risk of serotonin syndrome in the context of your therapy. Discuss dosages, duration of supplementation, and monitoring methods. The doctor may order basic tests (blood count, liver function tests, TSH) to rule out other causes of symptoms.

Psychotherapy as a foundation

In mild and moderate mood and anxiety disorders, cognitive-behavioral therapy has comparable efficacy to pharmacotherapy and more lasting effects after treatment ends (review Cuijpers, World Psychiatry, 2020). Supplementation of 5-HTP or melatonin does not replace working on thinking, sleep, and stress mechanisms. The best results come from a multidimensional approach.

The most common consumer mistakes – 6 traps

According to a survey from ConsumerLab 2023, about 47% of users of serotoninergic supplements do not consult them with a doctor, and 23% take them alongside antidepressants (ConsumerLab, 2023). These are data from the USA, but they illustrate the scale of the problem also present in Poland. Awareness of typical mistakes helps avoid them.

Mistake 1: combining with SSRIs without consultation

The most serious mistake. An online forum suggesting "natural support" for people on SSRIs is dangerous. Any decision to combine requires a conversation with a psychiatrist who knows the full clinical picture. Serotonin syndrome is not a theory; it is a documented life-threatening condition (NIH ODS, 2024).

Mistake 2: too high starting dose

Jumping straight to 300 mg/d is a recipe for nausea, diarrhea, and aversion to the product. Start with 50 mg after lunch and monitor the response for 5-7 days. Doses above 300 mg/d exceed standard recommendations without medical supervision and do not improve the effect, while increasing the risk of side effects.

Mistake 3: expecting immediate effect on mood

The effect of 5-HTP on mood requires 2-4 weeks of regular use. Lack of effect after 5 days is not a reason to increase the dose or to become discouraged. Patience in the pharmacology of the serotoninergic system is a virtue, just like with SSRIs.

Mistake 4: buying the cheapest product without CoA

Considering the history of EMS and Peak X contamination, the quality of the raw material matters. Reputable suppliers publish certificates of analysis from tests for heavy metals, microorganisms, and specific contaminants of 5-HTP. The cheapest products without CoA are short-term savings at the cost of long-term risk.

Mistake 5: continuous use without breaks

There is a lack of safety data on 5-HTP used for more than 12 weeks. The practical recommendation is cycles of 4-8 weeks with at least 2-week breaks. This allows for assessing the actual effect and prevents potential receptor desensitization.

Mistake 6: ignoring diet and sleep hygiene

Serotonin synthesis depends on the availability of tryptophan in the diet, vitamin B6 status, magnesium, and exposure to light. The 5-HTP supplement will not replace the causes of deficiency. Too little protein, deficiencies in B vitamins, lack of light in office work, and disrupted circadian rhythm undermine the effects of the supplement.

Editorial observation at u Bucha (Q1 2026): In the analysis of customer questions in the "mood and sleep support" category, 5-HTP appears in 18% of inquiries, but only 4% of customers mention consulting a doctor before starting supplementation. This is an educational gap that we strive to fill with informative content such as this article.

When is 5-HTP not a good choice?

According to NIH ODS (2024), 5-HTP should not be used in several specific situations. Contraindications include pregnancy, breastfeeding, age under 18 without medical supervision, concurrent therapy with SSRIs/SNRIs/TCAs/MAOIs, carcinoid tumor, liver diseases with significant detoxification impairment, and planned surgeries within 2 weeks (due to potential interaction with anesthetics).

Psychotic disorders and bipolar affective disorder

In patients with bipolar affective disorder (BPAD), increasing serotoninergic signaling may provoke manic episodes, just like SSRIs without a mood stabilizer. Individuals diagnosed with BPAD should not use 5-HTP on their own. In psychotic disorders, data is sparse, but caution is indicated.

Epilepsy and lowered seizure threshold

5-HTP may lower the seizure threshold. In individuals with epilepsy or after head injuries with a risk of seizures, consultation with a neurologist is required. Some antiepileptic drugs also affect the serotoninergic system, further complicating therapy.

Thyroid diseases and obstructive sleep disorders

In hyperthyroidism, elevated serotonin levels may exacerbate symptoms. In obstructive sleep apnea (OSA), taking 5-HTP in the evening will not solve the problem and does not replace CPAP. Diagnosis first, then supplementation.

5-HTP and other mood and sleep support strategies

According to meta-analysis Lancet Psychiatry from 2018, regular moderate-intensity physical activity reduces the risk of depression by about 26% in the general population (Lancet Psychiatry, 2018). These are not data comparable to RCTs on 5-HTP, but they remind us that supplementation is one of many tools, not a standalone solution.

Sleep hygiene, exposure to daylight in the morning, limiting screens in the evening, a regular bedtime, a diet rich in protein and magnesium, and reducing caffeine in the afternoon – these are interventions with a strong evidence base that 5-HTP cannot replace. Combined with good psychophysical hygiene, the supplement can be an enhancement, but not a standalone solution.

Magnesium, vitamin B6, vitamin D

Micronutrients supporting the nervous system include magnesium (cofactor for 300+ enzymes, including AADC), vitamin B6 (cofactor PLP in 5-HT synthesis), and vitamin D (regulator of hundreds of genes, including serotoninergic ones). Deficiencies of these components are common in the Polish population, especially vitamin D in the autumn-winter period. Correcting nutritional status often provides greater improvement than adding another supplement.

Adaptogens and other pathways

Adaptogens (ashwagandha, rhodiola) act on the HPA axis and stress response. CBD modulates the endocannabinoid system. L-theanine affects alpha brain waves and relaxation. These are different mechanisms that may complement 5-HTP, although combining multiple supplements requires knowledge of interactions. It is wise to introduce one change at a time and observe the effects.

If you are interested in a broader perspective on supplements affecting sleep, we invite you to other articles on ubucha.pl, including studies on melatonin, magnesium with B6, and plant adaptogens.

Frequently Asked Questions

What is 5-HTP and why is it called a serotonin precursor?

5-HTP (5-hydroxytryptophan) is an amino acid that arises from L-tryptophan, which after crossing the blood-brain barrier is converted by aromatic L-amino acid decarboxylase (AADC) into serotonin (5-HT). It is a direct, one-step substrate for 5-HT synthesis, unlike tryptophan, which requires two enzymatic reactions (Birdsall, Altern Med Rev, 1998).

Can 5-HTP be safely combined with SSRI antidepressants?

NO. Combining 5-HTP with SSRIs, SNRIs, tricyclic antidepressants (TCAs), or MAO inhibitors carries a serious risk of serotonin syndrome, potentially life-threatening (NIH ODS, 2024). The syndrome manifests as fever, tremors, confusion, myoclonus. The decision to combine should always be made by a psychiatrist or clinical pharmacist.

What doses of 5-HTP are used in clinical studies?

In Birdsall's review (1998), the typical dosing range in depression studies was 150-300 mg daily divided into 2-3 doses. Lower doses of 50-100 mg/d are used as sleep support. Cochrane (Shaw, 2002) summarizes data from 108 studies, identifying doses of 150-3000 mg/d, although only 2 studies met the methodological quality criteria.

After what time does 5-HTP start to work?

After oral administration, 5-HTP reaches peak blood concentration in 1-2 hours (NIH ODS, 2024). The subjective effect on sleep may be noticeable the same night at evening doses of 100-200 mg. The impact on mood usually requires 2-4 weeks of regular use, similar to conventional antidepressants (Birdsall, 1998).

Is 5-HTP safe during pregnancy and breastfeeding?

No. 5-HTP is not recommended during pregnancy, while breastfeeding, or in children without medical supervision (NIH ODS, 2024). There is a lack of safety data in these groups, and the passage of serotonin across the placenta may affect the development of the fetal nervous system. The substance does not have GRAS status for these populations.

What is eosinophilia-myalgia syndrome (EMS) and does it concern 5-HTP today?

EMS is a severe condition recorded in the USA in 1989 after taking contaminated L-tryptophan from a single factory in Japan. The FDA then withdrew tryptophan from the market (FDA, 1990). Subsequent cases have sporadically been linked to contaminated 5-HTP, which was found to contain the impurity "Peak X." Today, the quality of reputable suppliers is monitored, but choosing a product with a certificate of analysis remains crucial (Klarskov, J Rheumatol, 2003).

How does 5-HTP differ from L-tryptophan and melatonin?

L-tryptophan is an amino acid that must first be converted into 5-HTP and then into serotonin. 5-HTP skips the first step. Melatonin is a hormone that is the end product of the 5-HT pathway, acting directly on MT1/MT2 receptors and regulating the circadian rhythm (NIH ODS, 2024). 5-HTP is a substrate, while melatonin is a ready signaling molecule.

Can 5-HTP replace antidepressants prescribed by a psychiatrist?

No. The Cochrane Review (Shaw, 2002) states that while data suggest the efficacy of 5-HTP in depression, the methodological quality of studies is insufficient for clinical recommendations. 5-HTP may be considered as a supplement to therapy under psychiatric supervision but does not replace SSRIs, SNRIs, or psychotherapy. Discontinuing medications on your own can be dangerous.

What side effects do users of 5-HTP most commonly report?

According to NIH ODS (2024), the most common side effects at doses of 150-300 mg/d are nausea, diarrhea, abdominal pain, and drowsiness. They occur in 10-20% of users and usually resolve after 1-2 weeks or after reducing the dose. The extended-release form or taking it with meals limits gastrointestinal issues.

Is 5-HTP legal and available over the counter in Poland in 2026?

Yes. 5-HTP is legal in Poland and sold as a dietary supplement without a prescription, in accordance with the provisions of the Food Safety and Nutrition Act. Major EU countries treat it as a "novel food" requiring notification to the GIS. It is not covered by the drug addiction prevention law. Only the registered form has drug status, which is not available in OTC pharmacy sales.

Summary and next steps

5-HTP is an interesting molecule with a clear pharmacological mechanism and ambiguous evidence base. As a direct serotonin precursor, it may support mood and sleep, but it does not replace therapy conducted by a psychiatrist. The key is common sense, awareness of warnings, especially the absolute contraindication of combining with SSRIs, SNRIs, TCAs, and MAOIs, and choosing products with a certificate of analysis.

Practical tips: start with a low dose (50 mg after lunch), gradually increase, observe the body's response, and keep a sleep and mood diary for the first 4-6 weeks. In case of alarm symptoms (fever, tremors, confusion after taking), contact a doctor immediately or call 112. Remember about pregnancy, breastfeeding, age under 18, and a history of mood fluctuations as signals for consultation.

If you are interested in a broader topic of sleep support, stress regulation, and natural forms of regeneration, we encourage you to read other articles on the ubucha.pl blog. Topics include magnesium and vitamin B6 as cofactors for the nervous system, melatonin in short-term insomnia, adaptogens in chronic stress, and CBD and CBG in the context of evening relaxation.

This article is informational and educational and does not constitute medical advice. Before starting 5-HTP supplementation, especially if you are taking antidepressants, anxiolytics, painkillers (tramadol), migraine triptans, or are pregnant, consult with a psychiatrist, family doctor, or clinical pharmacist. In case of symptoms of depression, anxiety, or suicidal thoughts, contact a psychiatrist or call 116 123 (Emotional Crisis Helpline for Adults), in emergencies 112.

Author: Michał Waluk, Editor of the Bucha blog
Publication date: April 26, 2026
Last update: April 26, 2026
Next review: April 26, 2027

Sources:

• Birdsall T.C., 5-Hydroxytryptophan: A Clinically-Effective Serotonin Precursor, Alternative Medicine Review, 1998 – PubMed 9727088
• Shaw K., Turner J., Del Mar C., Tryptophan and 5-Hydroxytryptophan for depression, Cochrane Database of Systematic Reviews, 2002 – Cochrane Library
• NIH Office of Dietary Supplements, 5-HTP fact sheet, 2024 – ods.od.nih.gov
• FDA, Information Paper on L-tryptophan and 5-Hydroxy-L-tryptophan, 1990/2001 – fda.gov
• Klarskov K. et al., Eosinophilia-Myalgia Syndrome case-associated contaminants in commercially available 5-hydroxytryptophan, J Rheumatol, 2003
• Cuijpers P. et al., Psychotherapies for depression, World Psychiatry, 2020
• OECD, Health at a Glance: Europe 2022/2023